Skip to main navigation Skip to search Skip to main content

Differential Effects of the beta-Adrenoceptor Blockers Carvedilol and Metoprolol on SQT1-and SQT2-Mutant Channels

  • Ilona Bodi
  • , Gerlind Franke
  • , Naga Deepa Pantulu
  • , Kezhong Wu
  • , Stefanie Perez-Feliz
  • , Christoph Bode
  • , Manfred Zehender
  • , Axel Zur Hausen
  • , Michael Brunner
  • , Katja E. Odening*
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

-Blocker Effects on SQTS-Mutant K+ Channels BackgroundN588K-KCNH2 and V307L-KCNQ1 mutations lead to a gain-of-function of I-Kr and I-Ks thus causing short-QT syndromes (SQT1, SQT2). Combined pharmacotherapies using K+-channel-blockers and -blockers are ef
Original languageEnglish
Pages (from-to)1163-1171
Number of pages9
JournalJournal of Cardiovascular Electrophysiology
Volume24
Issue number10
DOIs
Publication statusPublished - Oct 2013

Keywords

  • beta-adrenergic blocker
  • carvedilol
  • metoprolol
  • potassium current
  • short-QT syndrome

Fingerprint

Dive into the research topics of 'Differential Effects of the beta-Adrenoceptor Blockers Carvedilol and Metoprolol on SQT1-and SQT2-Mutant Channels'. Together they form a unique fingerprint.

Cite this